Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-070149

Chief Operating Officer gave up 4,473 shares (to pay taxes)

  • Chief Operating Officer acquired 8,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2026-06-01 Option exercise +8,790 134,556 D
BILINSKY IGOR Chief Operating Officer 2026-06-01 Shares withheld for taxes −4,473 $3.96 $17,713 130,083 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2026-06-01 Option exercise · Restricted Stock Units −8,790 26,369 D
Loading xslF345X06/tm2616710-1_4seq1.xml…